Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors

被引:0
|
作者
Hong-tao Guo
Xue-han Bi
Ting Lei
Xiao Lv
Guang Yao
Yao Chen
Chang Liu
机构
[1] the First Hospital of Lanzhou University,Department of obstetrics and gynecology
[2] Key Laboratory of Gynecologic Oncology Gansu Province,undefined
来源
BMC Cancer | / 20卷
关键词
Cervical cancer; Chemotherapy; Radiotherapy; Squamous cell carcinoma antigen;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors
    Guo, Hong-tao
    Bi, Xue-han
    Lei, Ting
    Lv, Xiao
    Yao, Guang
    Chen, Yao
    Liu, Chang
    BMC CANCER, 2020, 20 (01)
  • [2] Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma
    Qin, Lin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 9167 - 9171
  • [3] Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma
    Lin Qin
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 9167 - 9171
  • [4] Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy
    Zhang, Guangyu
    Miao, Li
    Wu, Haijian
    Zhang, Youzhong
    Fu, Chunli
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [5] Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study
    Guo, Qinhao
    Zhu, Jun
    Wu, Yong
    Wen, Hao
    Xia, Lingfang
    Wu, Xiaohua
    Ju, Xingzhu
    EJSO, 2020, 46 (01): : 131 - 138
  • [6] PREDICTIVE VALUE OF PREOPERATIVE SERUM SQUAMOUS CELL CARCINOMA ANTIGEN (SCC-AG) LEVEL ON TUMOR RECURRENCE IN CERVICAL SQUAMOUS CELL CARCINOMA PATIENTS TREATED WITH RADICAL SURGERY: A SINGLE-INSTITUTION STUDY
    Guo, Q.
    Zhu, J.
    Ju, X.
    Wu, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A285 - A285
  • [7] Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage
    Xu, Fan
    Li, Yanfang
    Fan, Liangsheng
    Ma, Jing
    Yu, Lan
    Yi, Hongyan
    Chen, Xiaojing
    Wei, Wenfei
    Wu, Peng
    Liang, Li
    Hu, Huiquan
    Xing, Hui
    Wang, Wei
    JOURNAL OF CANCER, 2018, 9 (09): : 1660 - 1666
  • [8] DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SQUAMOUS CELL CARCINOMA ANTIGEN (SCC-AG) IN CERVICAL MALIGNANCY OF NORTH INDIAN POPULATION
    Sachan, R.
    Patel, M. L.
    Singh, M.
    Sachan, P.
    Natu, S. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 665 - 668
  • [9] TREATMENT RESULTS OF ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE-RISK CERVICAL CANCER
    Wen, H.
    Liu, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [10] CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma
    Zhang, Jingya
    Dong, Dong
    Wei, Qian
    Ren, Li
    BMC CANCER, 2022, 22 (01)